TScan Therapeutics Announces Transition of Chief Financial Officer
WALTHAM, Mass., June 29, 2023 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…
News
Corvus Pharmaceuticals Presents New Ciforadenant Preclinical Data at the 2nd JCA-AACR Precision Cancer Medicine International Conference
Preclinical data highlights ciforadenant’s mechanism of action and synergy with immune checkpoint inhibitors Enrollment continues…
Corvus Pharmaceuticals Presents New Ciforadenant Preclinical Data at the 2nd JCA-AACR Precision Cancer Medicine International Conference
Preclinical data highlights ciforadenant’s mechanism of action and synergy with immune checkpoint inhibitors Enrollment continues…
Plus Therapeutics Reports Positive Interim Updates from Two ReSPECT™ Clinical Trials at SNMMI Annual Meeting
ReSPECT-GBM Phase 1 recurrent glioblastoma trial demonstrates safety and overall survival correlation with absorbed radiation…
Plus Therapeutics Reports Positive Interim Updates from Two ReSPECT™ Clinical Trials at SNMMI Annual Meeting
ReSPECT-GBM Phase 1 recurrent glioblastoma trial demonstrates safety and overall survival correlation with absorbed radiation…
Genelux Corporation and TVAX Biomedical, Inc. announce the issuance of a United States patent covering the combination of an adoptive T cell therapy/oncolytic viral cancer treatment that is exclusively licensed to V2ACT Therapeutics™, LLC
– V2ACT Therapeutics™, LLC is a joint venture between Genelux Corporation and TVAX Biomedical, Inc….
Genelux Corporation and TVAX Biomedical, Inc. announce the issuance of a United States patent covering the combination of an adoptive T cell therapy/oncolytic viral cancer treatment that is exclusively licensed to V2ACT Therapeutics™, LLC
– V2ACT Therapeutics™, LLC is a joint venture between Genelux Corporation and TVAX Biomedical, Inc….
BioNTech and OncoC4 Initiate Pivotal Phase 3 Trial of BNT316/ONC-392 Program in Metastatic NSCLC
Initiation of pivotal Phase 3 trial in non-small cell lung cancer (NSCLC) marks the first…
BioNTech and OncoC4 Initiate Pivotal Phase 3 Trial of BNT316/ONC-392 Program in Metastatic NSCLC
Initiation of pivotal Phase 3 trial in non-small cell lung cancer (NSCLC) marks the first…
Kineta to Receive $5 Million Milestone Payment from Merck
Discovery stage milestone triggered by validating an undisclosed target for amyotrophic lateral sclerosis (ALS) SEATTLE,…
Kineta to Receive $5 Million Milestone Payment from Merck
Discovery stage milestone triggered by validating an undisclosed target for amyotrophic lateral sclerosis (ALS) SEATTLE,…
Verizon upgrades network for Spokane customers
Recent upgrades result in testing outcomes that show customers have the best experience on the…
Mobilicom Launches Cybersecure SDR Product with High Size-to-Performance Ratio, Expanding its Market into Mid-Sized Drones
Mobilicom’s MCU-70 expands communications range to 100 miles with improved link performance, more power, better…
Verizon upgrades network for Spokane customers
Recent upgrades result in testing outcomes that show customers have the best experience on the…
Akeneo Wins Retail Company of the Year in 2023 Globee Awards for American Business
Boston, Massachusetts–(Newsfile Corp. – June 29, 2023) – Akeneo, the Product Experience company, proudly announces…
Akeneo Wins Retail Company of the Year in 2023 Globee Awards for American Business
Boston, Massachusetts–(Newsfile Corp. – June 29, 2023) – Akeneo, the Product Experience company, proudly announces…
Virtual Assistant Staffing Agency Rebrands to SINQ, Pioneering Global Virtual Team Synchronization
Nashville, Tennessee–(Newsfile Corp. – June 29, 2023) – Virtual Assistant Staffing Agency is excited to…
Virtual Assistant Staffing Agency Rebrands to SINQ, Pioneering Global Virtual Team Synchronization
Nashville, Tennessee–(Newsfile Corp. – June 29, 2023) – Virtual Assistant Staffing Agency is excited to…
DelphX Announces Closing of First Tranche of Non-Brokered Unit Financing
Toronto, Ontario–(Newsfile Corp. – June 29, 2023) – DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB:…
DelphX Announces Closing of First Tranche of Non-Brokered Unit Financing
Toronto, Ontario–(Newsfile Corp. – June 29, 2023) – DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB:…